PRISM BioLab206A東証グロース医薬品FY ending Sep 2025, non-consolidated, J-GAAP
PRISM BioLab brought in ¥112.9M in revenue.
It lost about ¥440 for every ¥100 of sales at the operating level.
For every ¥100 PRISM BioLab sells, how much goes where, and how much is kept.
Margin funnel (derived from reported values)Gross margin 71.1% → Operating margin -440.0% → Net margin -466.6%
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.